Wednesday Closing Bell: Markets Can’t Hold Early Gains

October 30, 2013: U.S. markets opened higher again Wednesday morning as investors waited to hear the FOMC announcement later in the day. The ADP employment report came in weak while the consumer price index came in pretty much as expected. Mortgage applications rose for the week and higher crude oil inventories pushed crude prices down.

European markets closed mixed today, while Asian markets closed higher and Latin American markets closed lower.

Thursday's calendar includes the following scheduled data releases and events (all times Eastern):

7:30 a.m. – Challenger job cut report 8:30 a.m. – New claims for unemployment benefits 9:45 a.m. – Chicago PMI 10:30 a.m. – EIA weekly natural gas storage report 3:00 p.m. – Farm prices 4:30 p.m. – Fed balance sheet and money supply

Here are the closing bell levels for Wednesday:

S&P500 1763.31 (-8.64; -0.49%) DJIA 15618.76 (-61.59; -0.39) NASDAQ 3930.62 (-21.72; -0.55%) 10YR TNOTE 2.536% (-0.21875) Gold $1,349.30 (+3.80; +0.3%) WTI Crude oil $96.77 (-1.43; -1.5%) Euro/Dollar: 1.3735 (-0.0011; -0.08%)

Big Earnings Movers: LinkedIn Corp. (NYSE: LNKD) is down 9.4% at $223.90 after beating estimates but offering cautious guidance. General Motors Co. (NYSE: GM) is up 3.3% at $37.24 after beating estimates. Comcast Corp. (NASDAQ: CMCSA) is down 1.3% at $47.09 probably due to a loss of cable subscribers. Phillips 66 (NYSE: PSX) is up 1.7% at $65.22 after disappointing earnings. The Western Union Co. (NYSE: WU) is down 12.5% at $16.84 on a poor profit outlook for next year.

Stocks on the Move: NQ Mobile Inc. (NYSE: NQ) is up 11.6% at $12.29 as the company continues to claw its way back from an awful short-seller report. Criteo SA (NASDAQ: CRTO) is up 13.9% at $35.30 following its IPO today. Digital Realty Trust Inc. (NYSE: DLR) is down 15.3% at $49.16 on lowered guidance.

In all, 219 NYSE stocks put up new 52-week highs today, while only 13 stocks posted new lows.

Top Portfolio Products: New Arbitrage Fund from Touchstone Investments

New products and changes introduced over the last week include a new arbitrage fund from Touchstone Investments and a new program from Commonfund.

In addition, AllianceBernstein added a new share class and revamped the retirement section of its website.

Here are the latest developments of interest to advisors:

1) Touchstone Investments Launches Arbitrage Fund

Touchstone Investments recently announced the launch of the Touchstone Arbitrage Fund (TMACX), which is subadvised by Longfellow Investment Management Co. TMACX seeks to achieve positive returns regardless of market conditions over the long-term. It primarily invests in securities of companies that are involved in publicly announced mergers and other corporate reorganizations that have been defined and disclosed. Non-deal arbitrage and fixed-income complement the fund’s merger arbitrage investments. TMACX will be offered across several share classes.

The fund’s portfolio management team includes Barbara McKenna, who is managing principal and portfolio manager; Alexander Graham; David Stuehr; and John Villela. Collectively, the team brings more than four decades of arbitrage investing experience to Touchstone.

2) Commonfund Launches Multi-Asset Program, Announces New Appointments

On Thursday Commonfund formally announced its multi-asset program, which is designed to increase investment solutions and support for the company’s mid-sized (under $50 million in assets) non-profit clients. The firm also announced three new appointments.

Steven Snyder has been appointed to the position of managing director and head of the program. A 15-year veteran of the firm, he is currently managing director, head of client services.

Michael Strauss, current chief investment strategist and chief economist, will team with Snyder to communicate the firm’s points of view to investors in the program. He will also work with Snyder to construct new investment strategies.

Marc Bernhardt, currently a relationship officer serving program clients, has been appointed to the role of director, portfolio strategist. Reporting to Strauss, he will direct the investment team’s efforts in support of all clients of the program.

3) AllianceBernstein Launches Z Class of Retirement Shares, Enhances Website

AllianceBernstein L.P. announced Wednesday that it will now offer a new nonrevenue share class, Z shares, for a select group of mutual funds. Z shares will be the lowest-priced share class for the firm’s funds. They became available for purchase on Wednesday for the following funds: AllianceBernstein Core Opportunities Fund (ADGZX); AllianceBernstein Discovery Value Fund (ABSZX); AllianceBernstein Equity Income Fund (AUIZX); AllianceBernstein Global Bond Fund (ANAZX); AllianceBernstein Growth and Income Fund (CBBZX); and AllianceBernstein High Income Fund (AGDZX).

Z shares are offered without 12b-1 fees or subtransfer agency fees and there is no minimum initial investment requirement. In addition, the firm will not make distribution services and educational support payments in respect of Class Z shares.

AllianceBernstein has also introduced a series of enhancements to the retirement section of its website. The newly revamped Retirement Leaders website provides tools and resources for retirement-focused advisors, including a personalized home screen with access to retirement practice-management resources, industry trends, interactive tools, recent legal and regulatory updates, tools to help build investment menus and other topics.

Read the Oct. 11 Portfolio Products Roundup at ThinkAdvisor.

Jim Cramer's Top Stock Picks: CRZO CELG REGN GILD BMRN

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Tuesday's "Mad Money" on CNBC:

CRZO data by YCharts

Carrizo Oil & Gas (CRZO): Cramer said Carrizo is still one of the best untapped oil and gas drillers our country has to offer.

Best Stocks To Invest In

CELG data by YCharts

Celgene (CELG), Regeneron (REGN) and Gilead Sciences (GILD): Cramer said fund managers will be piling into these hot biotechs just as soon as this week's selloff has run its course.

BMRN data by YCharts

BioMarin Pharmaceuticals (BMRN): Orphan drugs continue to deliver remarkable returns for shareholders, said Cramer -- just look at BioMarin's chart.

To read a full recap of "Mad Money" on CNBC, click here.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned. Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money." None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on TheStreet.com. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

Are Data REITs For You?

The Intelligent REIT Investor's Brad Thomas discusses his outlook for real estate and the new class of data REITs.

SPEAKER:  Hi, I'm talking with Brad Thomas today about REITs.  Thank you for joining me, Brad. 

BRAD THOMAS:  Oh, glad to be here, thanks so much. 

SPEAKER:  You're welcome.  You know, we talked a couple of months ago and you were saying to me that there were a couple of things that investors really need to think about when they're investing in REITs, and one was what is the dividend yield, obviously, and second is the safety of that dividend.  So can you expand a little bit on that? 

BRAD THOMAS:  Sure.  Well, you know, REITs today are very attractive for investors because investors are looking for dividends and dividend safety.  You must remember that REITs are unlike any other public company in that they pay out dividends, forced dividends, and what I mean by that is by law, which is a law created in 1960 in the Eisenhower administration, so this is a law that was created over five decades ago, just point that out, that REITs are required to pay out 90% of their taxable income in the form of dividends, so that's created a very sustainable model for investors today.  That's what's attracted investors to this real estate secured industry because of the sustainability of the dividend model.  So we're seeing a lot of high dividends today, again because companies are forced to pay out at least 90%.  In most cases they pay out almost 100% of their taxable income in the form of dividends. 

SPEAKER:  But now, what happens if an investor owns a REIT and there's a cut in the dividend?  I mean, do you panic immediately? 

BRAD THOMAS:  Well, I mean we did see that. 

SPEAKER:  Yes, we did. 

BRAD THOMAS:  Great recession, but remember it was not only REITs -

SPEAKER:  Yes. 

BRAD THOMAS:  - everybody panicked.  I think quite a few companies panicked, but what's interesting is one of my mantras is huge failure makes for huge success.  I think that's really important, not only in the REIT business but any company today, but especially in the REIT sector which is the sector that I cover.  We're seeing a tremendous recovery in the real estate market today. 

SPEAKER:  Yes. 

BRAD THOMAS:  I like to refer to every business has a cycle. 

SPEAKER:  Yes. 

BRAD THOMAS:  Real estate is typically a seven to eight to nine-year cycle, so I like to say we're in the bottom of the third inning.  There's still a tremendous amount of growth ahead.  We're seeing, at least the economy is starting to recover.  Interest rates haven't started to rise yet.  We're talking about a rise in interest rates, and remember when interest rates rise that means the economy is performing well. 

SPEAKER:  Correct. 

BRAD THOMAS:  So again, I think real estate is definitely an asset class that I recommend for any investment portfolio today. 

SPEAKER:  And you also, when I spoke with you in May you were talking about data REITs.  Can you tell us a little bit about what the heck is a data REIT and what does that mean for investors? 

BRAD THOMAS:  Sure.  Well, I was actually over in Digital Realties headquarters today here in San Francisco, just right down the street, and Digital, ticker symbol DLR, they're one of the largest, actually they are the largest data sector REIT in the country.  This is a fairly new sector.  I mean, you know, we didn't have Facebook and Amazon ten years ago. 

SPEAKER:  Right. 

BRAD THOMAS:  So, you know, the fundamental value proposition for a data REIT is all of this data in my phone and your phone and these pictures of kids and grandchildren, where's that data stored today? 

SPEAKER:  Yes. 

BRAD THOMAS:  Where's all the business data stored today?  So there's a tremendous growth in this sector, supply and demand is very important today, so tremendous growth opportunities.  Digital's got around $10 billion market cap.  There are some smaller data sector REITs out there like Serex and Equinex (SP?) which is actually talking about converting to say REIT structure. 

SPEAKER:  Yes, they haven't done that yet, have they? 

BRAD THOMAS:  Right.  No, they've announced, and it's very large, it will be about at least a $10 billion company, so you're seeing when you aggregate all of the data storage product, not only public but also private and a lot of it is private equity driven, there's certainly a lot of real estate out there today so it's a very sustainable model.  Digital by the way, you talk about dividends we addressed earlier.  Dividend (SP?) has never cut a dividend.  They've been a public company for nine years -

SPEAKER:  That's great. 

BRAD THOMAS:  - and not only have they not cut the dividend, they've increased it every year in a row, so that tells you something about the data sector. 

SPEAKER:  Sure, good sector.  Thank you very much. 

BRAD THOMAS:  Sure, you're welcome. 

SPEAKER:  And thanks for being with us on the MoneyShow.com video network.

Hot Casino Stocks To Own Right Now

If you keep track of the markets during the average day, it is hard not to get sucked into the vortex of noise.

The media and pundits seem at times to act almost as shills and casino hosts encouraging players to pick up the action and move the money around looking for a win. The constant discussion of short term events that have little to no bearing on the long term goals and objectives can knock the most disciplined investor off their game.

The only two things that really matter to an asset based value investor are price in relation to value and margin of safety.

Nothing else not matter how worked up the talking heads may be at various times of the trading day.

Some of the things that are seriously pondered and considered during the day border on the ridiculous. Right now the talk of the day every day focuses on taper. Traders and money managers wax eloquent and the timing and pace of the Feds winding down of their bond buying program.

See also: Give The Gift Of Value This Holiday Season

Hot Casino Stocks To Own Right Now: NanoTech Entertainment Inc (NTEK)

NanoTech Entertainment, Inc. (NanoTech), formerly Aldar Group, Inc., is a provider of gaming technology for the coin-op arcade, casino gaming and consumer gaming markets. The Company operates as a manufacturer, developing technology and games, and then licensing them to third parties for manufacturing and distribution. As of June 30, 2009, the Company�� products included MultiPin, Xtreme Rally Racing, NanoNET Online System, Pinball Wizard, Mot-Ion Adapter, Opti-Gun Adapter and Retr-IO Adapter. In April 2009, the Company acquired NanoTech Entertainment, Inc. In July 2013, NanoTech Entertainment Inc completed the acquisition of Clear Memories, Inc. of Napa California. Effective August 9, 2013, NanoTech Entertainment Inc acquired Worldwide Global Entertainment, a developer of prepackaged software.

The Company�� physics engine and motion sensors allow MultiPin to accurately recreate the experience of a mechanical pinball machine, while providing players with a variety of classic and modern pinball games to choose from. Xtreme Rally Racing is a driving machine that features three modes of game play: Xtreme Off-Road-Race Head to Head against other players and the computer to checkpoints while driving anywhere on the map with no preset course; Timed Rally Stages-Classic Rally Racing on real world courses. Players will be able to race in five different countries on real world rally courses, and Xtreme Stadium Racing-Custom Stadiums designed for Xtreme racing, including a figure eight multi-lap course with huge jumps. NanoNET Online System is remote operator control of machines, including diagnostics, accounting reports, and automatic software updates and enhancements downloaded over the net.

The Company has created the input device designed to give the pinball players a way to experience real pinball controls on their personal computer. Based on the technology developed for the MultiPin product it has built a controller that lets people play pinball using traditional controls and! the ability to shake and nudge the table. The Mot-Ion adapter is a universal serial bus (USB) adapter that allows do it yourself Pinball enthusiasts to build their own cabinet using real pinball controls providing analog inputs for nudging and bumping. The OptiGun adapter is a USB adapter that allows players to connect Arcade Light Guns to any USB based system. The Retr-IO adapters provide a standard JAMMA interface for USB based systems.

Advisors' Opinion:

• [By Peter Graham]

  Nyxio Technologies Corp (OTCMKTS: NYXO), COREwafer Industries Inc (OTCMKTS: WAFR) and NanoTech Entertainment, Inc (OTCMKTS: NTEK) are three small cap stocks in some very diverse industries. In fact, one of these stocks just bought a 3D ice sculpture business. So will investors see their investment melt with that small cap stock�along with the other two? Here is a closer look to help you decide for yourself:��

Hot Casino Stocks To Own Right Now: MGM Resorts International(MGM)

MGM Resorts International, through its subsidiaries, primarily owns and operates casino resorts in the United States. The company?s resorts offer gaming, hotel, dining, entertainment, retail, and other resort amenities. It also owns and operates golf courses and a golf club. As of December 31, 2010, the company owned and operated 15 properties located in Nevada, Mississippi, and Michigan; and has 50% investments in 4 other casino resorts in Nevada, Illinois, and Macau. In addition, MGM Resorts International has an agreement with the Mashantucket Pequot Tribal Nation, which owns and operates a casino resort in Connecticut, to carry the ?MGM Grand? brand name. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.

Advisors' Opinion:

• [By Travis Hoium]

  Any thought that the Las Vegas gaming market would recover quickly after the recession has long since been lost, but there is a slow and steady recovery taking place in Sin City. High-end operators Las Vegas Sands (NYSE: LVS  ) and Wynn Resorts (NASDAQ: WYNN  ) have been seeing improved results as wealthy customers return to the casinos, but the lower end of the market, where MGM Resorts (NYSE: MGM  ) and Caesars Entertainment (NASDAQ: CZR  ) play, has been choppy to say the least.

• [By Travis Hoium]

  But there's still evidence that it exists, even if authorities don't push hard for information. MGM Resorts (NYSE: MGM  ) was forced to divest its New Jersey properties because of the company's relationship with Pansy Ho, whose father had ties to triads in Macau. Las Vegas Sands is under investigation by the U.S. attorney's office for possibly violating money laundering laws in Macau last year.

Top Medical Companies To Buy For 2014: (XTRN)

Las Vegas Railway Express Inc. focuses to re-establish a conventional passenger train service between the Las Vegas and Los Angeles metropolitan areas. It plans to establish a ?Vegas-style? passenger train service. The company is based in Las Vegas, Nevada.

Hot Casino Stocks To Own Right Now: Pinnacle Entertainment Inc.(PNK)

Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L'Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.

Advisors' Opinion:

• [By Travis Hoium]

  What: Shares of Ameristar Casinos (NASDAQ: ASCA  ) and Pinnacle Entertainment (NYSE: PNK  ) fell as much as 11% today after the government brought into question the merger of the two companies.

• [By Sean Williams]

  Time to make the switch
  If I could name a sector that I'd certainly tread lightly around considering that consumers are tightening their wallets, it would be the casino sector. Casino companies rely on loose wallets and vacations to drive profits. This is why I feel it could be the time to say goodbye to casino and race track operator Pinnacle Entertainment (NYSE: PNK  ) near its 52-week high.

Hot Casino Stocks To Own Right Now: Umax Group Corp (UMAX)

Umax Group Corp., incorporated on March 21, 2011, is a development-stage company. The Company focuses to develop and distribute its product to the arcade and entertainment industry. The Company�� products include Rocket Launch, is Strength testing game which allows players to test their pushing/ throwing strength; Space Hockey, is a two player hockey game - each player must score as many as possible goals and Boxer, is a Simple punch testing game: insert coin/token/bill, press start button, hit the punch bag, wait for result, and try to beat opponent�� score or high score.

As of April 30, 2013, the Company had no revenues. The Company has developed its business plan, and executed exclusive distribution contract GEO a private enterprise, where it engages GEO as an independent contractor for the specific purpose of developing, manufacturing and supplying games for the Company.

Monday's Top Upgrades (and Downgrades)

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, with earnings season in full swing, we're seeing mainly analyst reactions to earnings news. Specifically, today we'll be looking at a pair of price target hikes for General Electric (NYSE: GE  ) and Honeywell (NYSE: HON  ) , followed by a downgrade for Nokia (NYSE: NOK  ) . Let's dive right in.

"General-ly" good news
We'll start off with General Electric which, at a $255 billion in market cap, is an economic bellwether that rings quite a bit louder than Honeywell, at $65 billion. This morning, The Wall Street Journal started off the week on a down note, lamenting recent disappointing economy and corporate-earnings reports -- slow retail sales growth of 0.4% in June, declining restaurant sales, and economist forecasts of only 1.5% annualized GDP growth in Q2.

If that's truly where the U.S. economy is heading, though, then somebody didn't get the memo, and that somebody is General Electric.

GE reported pretty anemic profits in Q2, granted, but the CEO also noted that six of his seven business segments were growing sales, with profit margins improving, and orders for new equipment simply flooding through the front door -- up 20% in the U.S. GE's now predicting strong growth in the second half of this year, and this good news inspired analysts at Argus Research to boost their target price on the shares by more than 10%, to $28 apiece.

So... who is right here? GE, or the WSJ? Honestly, it's hard to say, but with GE stock down 0.8% in early trading today, it appears investors are so far siding with the newspaper's view of the economy. And as good a report as GE put out last week, I cannot say that I blame investors for being cautious. GE shares, at 18.4 times earnings today, don't offer much -- or indeed, any -- margin of safety if all the company manages to do is grow at the 11% long-term rate Wall Street predicts for the company.

A 3.2% dividend yield is nice, sure, and helps to close the gap between price and value. But without faster growth, it's hard to see how this company can qualify for a buy rating, and hard to see how it can reach the new $28 price target Argus has set for it.

Second verse, same as the first 
I've got similar reservations about Honeywell, and the new $91 price target that RBC Capital Markets just set for that stock.

Robust gains in cash flow, improvement in profit margins, and a small gain in sales were the big news at Honeywell last week. (Also, there was the little matter of a small piece of electrical equipment hidden deep within a very large Boeing airplane, that's attracting some negative press.) Once again, this is a company that's not cooperating with the official view of a weak U.S. economy.

The valuation picture at Honeywell is, if anything, even less attractive than what we see at GE. Honeywell shares cost nearly 21 times earnings, or about 13% more than GE. These shares are expected to grow at closer to 10% per year over the next five years, however -- 6% slower than GE. And the dividend yield at Honeywell, an even 2%, is 38% worse than what GE pays out.

Long story short, if GE's valuation makes you nervous, Honeywell's should worry you even more.

Knocking Nokia
If there's one analyst move today that I do agree with, though (and don't get excited -- this is not good news), it's about Nokia. Analysts at Oppenheimer just knocked the stock down one notch to underperform, warning investors that far from reviving, Nokia's handset business looks more likely to drag down the rest of the company along with it.

Oppy sees a risk to Nokia's strategy of building high-quality smartphones equipped with superb camera optics... and selling them cheaply. Specifically, the analyst warns that Apple and Samsung are working to discount their phone offerings as well, and to shrink the price gap with Nokia's wares. As a result, Nokia's starting to look like it's caught in a price war that it cannot hope to win. Unprofitable already, and with an operating profit margin of just 5.5%, Nokia's phones business is ill-positioned to compete on price with Apple and its 30%-plus operating margin, for example.

Meanwhile, although the company has cut its rate of cash burn, and actually generated positive operating cash flow over the past year, its free cash flow number remains stuck in negative territory.

The upshot: While Oppenheimer likes Nokia's telecom equipment business, Nokia Siemens Networks, it holds out few hopes for the company as a whole. At least, not until the Lumia business starts gaining more traction in the marketplace.

Fool contributor Rich Smith owns shares of Apple. The Motley Fool recommends Apple. The Motley Fool owns shares of Apple and General Electric Company.

link

10 Best Clean Energy Stocks To Invest In 2014

With shares of Molycorp (NYSE:MCP) trading around $5, is MCP an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Molycorp engages in the production and sale of rare earth products that include oxides, metals, alloys, and magnets for various inputs in existing and emerging applications comprising clean energy technologies, multiple high-tech uses, defense applications, and water treatment technology. The research and exploration of rare earth products has been a hot trend in recent times. If these products to indeed produce significant results, companies like Molycorp stand to see explosive growth. As these technologies continue to be developed, look for Molycorp to make enormous profits if they become mainstream.

T = Technicals on the Stock Chart are Weak

Molycorp stock has witnessed a fair amount of selling pressure that has taken it to relatively low prices. The stock seems to be stabilizing at these prices but there does not seem to be an indication of a trend. Analyzing the price trend and its strength can be done using key simple moving averages. What are the key moving averages? The 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, Molycorp is trading slightly below its key averages which signal neutral to bearish price action in the near-term.

10 Best Clean Energy Stocks To Invest In 2014: Daimler AG (DDAIF)

Daimler AG (Daimler), incorporated on May 6, 1998, develops, manufactures, distributes and sells a range of automotive products, mainly passenger cars, trucks, vans and buses. It also provides financial and other services relating to its automotive businesses. The Company offers its automotive products and related financial services primarily in Western Europe and in the North American Free Trade Agreement (NAFTA) region, which consists of the United States, Canada and Mexico. During the year ended December 31, 2009, the Company derived approximately 46% of its revenue from sales in Western Europe and 21% from sales in the United States. It operates in five segments: Mercedes-Benz Cars, Daimler Trucks, Mercedes-Benz Vans, Daimler Buses and Daimler Financial Services. Its other business interests consist primarily of its equity investments in the European Aeronautic Defence and Space Company EADS N.V. (EADS) and in Tognum AG. In October 2009, Deutsche Bank AG completed the disposal of its interest in the Company. In June 2011, Daimler AG and Rolls-Royce Holdings PLC had secured around 94% interest in Tognum AG-DJ.

Mercedes-Benz Cars

Mercedes-Benz Cars designs, produces and sells Mercedes-Benz passenger cars, Maybach luxury sedans and smart micro compact passenger cars. During 2009, Mercedes-Benz Cars contributed approximately 51% of the Company�� revenue. The Company offers Mercedes-Benz passenger cars with a range of diesel and gasoline engines. Under the AMG brand, it offers versions of Mercedes-Benz vehicles with V8 or V12 engines in all classes, except in the A-, B-, R-, GL- and GLK-Classes. The Mercedes-Benz passenger car product range consists of S-Class, E-Class, C-Class, A-/B-Classes and ML-/R-/G-/GL-/GLK-Classes.

The S-Class is a line of luxury sedans, which are available in short and long wheelbase versions. In June 2009, the Company introduced a new generation of the S-Class sedans, including a hybrid version, the new S 400 BlueHYBRID. The S-Class sed! ans are complemented by the CL, a top-of-the-line two-door coupe, and the SL, a luxury roadster. The E-Class is a line of luxury sedans, coupes, convertibles and station wagons. It also offers the CLS, a four-door coupe based on the E-Class. The C-Class is a line of compact luxury sedans and station wagons. The CLC Sports Coupe and the SLK, a two-seat roadster, complement the C-Class product family.

The A-Class is a front wheel drive compact and the B-Class is a front wheel drive 4-door Compact Sports Tourer (CST). The Company does not offer the A- and B-Classes in the United States. The ML-Class is a line of sport utility vehicles with permanent all-wheel drive. The R-Class is a line of SUV Tourers, which is available in a short and a long wheelbase version. The GL-Class is a line of seven seat luxury sport utility vehicles. The GLK-Class is a line of compact sport utility vehicles. The G-Class is a line of cross country vehicles with permanent four-wheel drive that come in a short and a long wheelbase version, and as a convertible. Under the Maybach brand, the Company offers a line of luxury sedans with outstanding luxury, comfort, and individuality. Maybach sedans are available in a short and a long wheelbase version, including the Maybach 57S and 62S as sportier variations. The smart brand represents a micro compact car concept. It offers two models, the smart fortwo coupe and the smart fortwo cabrio.

Daimler Trucks

Daimler Trucks manufactures and sells trucks and specialty vehicles under the brand names Mercedes-Benz, Freightliner, Western Star, Thomas Built Buses and Fuso. During 2009, Daimler Trucks contributed approximately 21% of its revenue. During 2009, the Company ceased production of trucks under the Sterling brand name. The Company�� European Mercedes-Benz truck lines consist of the Actros and the Axor in the heavy-duty category, the Atego in the medium-duty category, and the specialty vehicles Econic and Zetros. The Unimog, a four-wheel drive ve! hicle for! special purpose applications, complements the line-up. In Turkey and Brazil, it manufactures heavy-duty and medium-duty trucks for the respective local and certain export markets. Its Mercedes-Benz trucks range from 6 metric tons gross vehicle weight (GVW) to 41 metric tons GVW.

The Company�� United States subsidiary, Daimler Trucks North America LLC, manufactures trucks and buses (based on truck chassis) in Classes 3 through 8 (from 9,000 lbs. GVW to 160,000 lbs. GVW) and sells them under the Freightliner, Western Star, and Thomas Built Buses brand names, primarily in the NAFTA region. It also manufactures chassis for trucks, buses, walk-in vans and motor homes in Classes 3 through 7 (from 10,000 lbs. GVW to 33,000 lbs. GVW). During 2009, Freightliner introduced a new version of the Coronado, an on-highway truck. It Japan-based subsidiary, Mitsubishi Fuso Truck and Bus Corporation (MFTBC), offers a truck portfolio and several bus lines, primarily for the Japanese and other Asian markets. The line-up includes the Canter trucks (light-duty), the Fighter trucks (medium-duty) and the Super Great trucks (heavy-duty) and also certain bus models (Rosa and Aero). MFTBC also sells trucks in Africa, Australia, Europe, Latin America and the United States.

Mercedes-Benz Vans

Mercedes-Benz Vans designs, manufactures and sells vans under the brand names Mercedes-Benz and Freightliner. During 2009, Mercedes-Benz Vans contributed approximately 8% of its revenue. The Company offers three lines of Mercedes-Benz vans between 1.9 metric tons (t) and 7.5t gross vehicle weight (GVW): the Vario, the Vito/Viano and the Sprinter. In the NAFTA region it sells the Sprinter under the Freightliner brand name and, since January 1, 2010, also under the Mercedes-Benz brand name. As of December 31, 2009, subsidiaries of Chrysler Holding LLC sold the Sprinter in the United States under the Dodge and Freightliner brand names, and in Canada under the Dodge brand name.

Daimler Buse! s

!

Daimler Buses is a global supplier in the worldwide bus market. During 2009, Daimler Buses contributed approximately 5% of the Company�� revenue. Its product portfolio includes city buses, coaches, intercity buses, midi buses and bus chassis. It sells complete buses under the Mercedes-Benz and Setra brands in Europe, under the Mercedes-Benz brand name in Mexico, and under the Setra and Orion brand names in the United States and Canada. In addition, Daimler Buses produces and sells worldwide a range of bus chassis under the brand name Mercedes-Benz.

Daimler Financial Services

The Company�� financial services activities contributed approximately 15% of its revenue during 2009. It consists principally of financing and leasing services supporting its Mercedes-Benz and other vehicle businesses. The financial services the Company offers consist mainly of customized financing and leasing packages for its retail and wholesale customers in the automotive sector. It also provides financing to its dealers for vehicle inventory and property, plant and equipment purchases, and it offers insurance brokerage and fleet management services, including dealer property and casualty insurance. In Germany, the Company operates a licensed bank, the Mercedes-Benz Bank. The Mercedes-Benz Bank offers financial services to its customers and employees in Germany. These services include leasing and sales financing services, car savings plans, credit cards and demand deposit accounts. In addition, the Mercedes-Benz Bank operates branches in Great Britain and Spain to refinance the local dealer portfolios.

The Company competes with BMW, Volkswagen, Fiat, Ford, General Motors, PSA, Renault, Tata Motors, Toyota, Honda, Nissan, Suzuki, Scania, Iveco, Volvo, DAF, Navistar International, Paccar, Hino, Isuzu, MAN Commercial Vehicles, Irisbus and Agrale.

Advisors' Opinion:

• [By WWW.GURUFOCUS.COM]

  German car manufacturers such as Volkswagen AG (VLKAY) and Daimler AG (DDAIF) have a great reputation in the global auto industry. As the U.S. economy recovers and China experiences great demand for imported vehicles, both these firms anticipate huge benefits. However, while Daimler is on a straight path to success, Volkswagen has been struggling as of late.

• [By John Rosevear]

  Mercedes-Benz is one of the great luxury car brands of all time, but parent company Daimler (NASDAQOTH: DDAIF  ) hasn't been happy with it lately. The problem: Profits trail those at German arch-rivals Audi and BMW (NASDAQOTH: BAMXF  ) .

• [By John Rosevear]

  Audi had about 29% of the Chinese luxury-car market last year. Together with German archrivals BMW (NASDAQOTH: BAMXF  ) and Mercedes-Benz (NASDAQOTH: DDAIF  ) , German brands account for about three-quarters of China's luxury-vehicle sales.

10 Best Clean Energy Stocks To Invest In 2014: Yangaroo Inc(YOO.V)

Yangaroo Inc., a technology company, enables secure business to business distribution of media via the Internet. It offers digital media distribution system (DMDS), a Web-based delivery system that enables secure digital file distribution by incorporating biometrics, encryption, and watermarking. The company?s DMDS replaces the physical distribution of audio and video content for music, music videos, and advertising to television, radio, media, retailers, award shows, and other authorized recipients with digital delivery of broadcast quality media through the Internet. It offers DMDS Music that delivers new music to broadcasters, radio programmers, journalists, and other industry influencers; and DMDS Advertising, which delivers audio and video files to broadcasters. Yangaroo Inc. serves music and advertising industries. The company was formerly known as Musicrypt.com Inc. and changed its name to Yangaroo Inc. in July 2007. Yangaroo Inc. was founded in 1999 and is headqua rtered in Toronto, Canada.

Best Small Cap Companies To Invest In Right Now: Dexus Property Group (DXS.AX)

DEXUS Property Group owns, manages, and develops office, industrial, and retail properties in Australia, New Zealand, the United States, France, Germany, and Canada. It also develops and manages office, industrial, and retail properties on behalf of third party investors. The company provides office space in various locations for corporate tenants, and local, state, and federal governments; specializes in premium business parks, industrial estates, and logistics and distribution facilities; and manages and develops retail assets. Its property portfolio consists of approximately 260 office, industrial, and retail properties. DEXUS Property Group, formerly known as DB RREEF Trust, is headquartered in Sydney, Australia.

10 Best Clean Energy Stocks To Invest In 2014: Five Below Inc (FIVE)

Five Below, Inc. (Five Below), incorporated on January 30, 2002, is a retailer offering a range of merchandise for teen and pre-teen customer. The Company offers products, including select brands and licensed merchandise across a number of categories, which it refer to as worlds-Style, Room, Sports, Media, Crafts, Party, Candy and Seasonal (which it refer to as Now). As of October 27, 2012, The Company operated 243 stores throughout the eastern half of the United States. Its Style consists primarily of accessories such as novelty socks, sunglasses, jewelry, scarves, gloves, hair accessories and attitude t-shirts. Its beauty offering includes products such as nail polish, lip gloss, fragrance and branded cosmetics. Its Room consists of items used to complete and personalize its customer�� living space, including glitter lamps, posters, frames, fleece blankets, pillows, candles, incense and related items. The Company also offers storage options for the customer�� room and locker.

The Company�� Sports consists of an assortment of sport balls, team sports merchandise and fitness accessories, including hand weights, jump ropes and gym balls. It also offers a variety of games, including name brand board games, puzzles, toys and plush items. In the summer season, its sports offering also include pool, beach and outdoor toys, games and accessories. Its Media consists of a selection of accessories for personal computers (PCs), cell phones, Moving Picture Experts Group Layer-3 Audio (MP3) players and tablet computers. The offering includes cases, chargers, headphones and other related items. It also carries a range of media products including books, video games and Digital Versatile Disc (DVDs). It offers an assortment of craft activity kits, as well as arts and crafts supplies, such as crayons, markers and stickers. It also offer trend-right items for school, such as backpacks, fashion notebooks and journals, novelty pens and pencils, as well as everyday name brand items.

The C! ompany�� Party consists of party goods, decorations and greeting cards, as well as everyday and special occasion merchandise. Its Candy consists of branded items that appeal to teens and pre-teens. This category includes an assortment of classic and novelty candy bars and movie-size box candy, as well as gum and snack food. It also sells chilled drinks through coolers. Its Seasonal consists of seasonally-specific items used to celebrate and decorate for events such as Christmas, Easter, Halloween and St. Patrick�� Day.

Advisors' Opinion:

• [By Dan Caplinger]

  On Wednesday, Five Below (NASDAQ: FIVE  ) will release its latest quarterly results. But with the stock finally giving up some ground after having soared since its IPO last summer, investors really want to see positive results from the company this time around.

• [By Rick Aristotle Munarriz]

  Alamy Legend has it that there's a list separating the naughty and nice kids this time of year. The same thing can be said about retailers, and only some are expected to be on Santa's good list this year. Let's go over some of the merchants that analysts predict will see double-digit revenue growth during retail's most important quarter. Michael Kors (KORS) -- Holiday quarter sales expected to rise 35 percent The hot name in designer handbags and accessories isn't Coach (COH) anymore. In fact, Coach saw sales and earnings dip slightly in its latest quarter. The luxury brand that folks clamor for these days is Kors. The average Kors store sold 23 percent more in its latest quarter than it did a year earlier, and that's exactly the kind of momentum that investors like to see heading into the critical holiday shopping season. Between expansion and store-level performance, Kors should be one of the biggest retail winners this quarter. Five Below (FIVE) -- Holiday quarter sales expected to rise 25 percent There are plenty of dollar stores out there, but this "cheap chic" hub sets the bar at $5 or less. The extra pricing wiggle room gives it more room to offer clothing, gadgets, and house wares that folks can actually use. Five Below's appeal stems largely from its fashion-forward focus. It's the "dollar" store that teens and young adults don't mind shopping at, and with just 276 stores out there Five Below still has plenty of expansion room to tackle. Conn's (CONN) -- Holiday quarter sales expected to rise 37 percent Consumer electronics isn't the growth industry that we many imagined it would be in this era of smartphones and tablets. Market leader Best Buy (BBY) isn't expected to grow holiday sales at all this quarter. Folks buying smartphones, tablets, and new video game consoles were the same ones buying pricier TVs and laptops in prior years. Conn's is different. Consumer electronics is just one of the many things that it's known for since it's a big pl

• [By Paul Ausick]

  Specialty retailer Five Below Inc. (NASDAQ: FIVE) gets a nod for its holiday ad. Sterne Agee analysts compared a basket of 12 advertised products with prices at Amazon.com Inc. (NASDAQ: AMZN) and with 4 products at Wal-Mart Stores Inc. (NYSE: WMT). Five Below�� price for the 12 items was $60 (exactly $5 apiece), compared with an Amazon price of $143.51. The analysts also compared the Five Below price to the lowest price it could find for each of the items at any retailer selling through Amazon. That basket cost $81.95 through Amazon, more than 36% higher than the Five Below price. For the four items sold at Walmart, Five Below�� prices were about 65% lower. Sterne Agee rates Five Below a Buy with a price target of $56. The stock is trading down about 0.5% at $53.20 in a 52-week range of $27.75 to $55.28.

• [By Roberto Pedone]

  Another stock that's quickly pushing within range of triggering a major breakout trade is specialty retailer Five Below (FIVE), which offers merchandise targeted at the teen and pre-teen customer. This stock is off to a strong start in 2013, with shares up 54%.

  >>5 Stocks Under $10 Set to Soar

  If you look at the chart for Five Below, you'll notice that this stock has been uptrending strong for the last month and change, with shares pushing higher from its low of $42.42 to its recent high of $50.39 a share. During that uptrend, shares of FIVE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of FIVE within range of triggering a major breakout trade.

  Traders should now look for long-biased trades in FIVE if it manages to break out above its all-time high at $50.39 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 835,622 shares. If that breakout triggers soon, then FIVE will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $60 to $65 a share.

  Traders can look to buy FIVE off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $47.13 a share or around $46 a share. One can also buy FIVE off strength once it takes out its all-time high at $50.39 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

10 Best Clean Energy Stocks To Invest In 2014: Semtech Corporation(SMTC)

Semtech Corporation, together with its subsidiaries, designs, produces, and markets analog and mixed-signal semiconductor products. The company?s product lines include protection products comprising filter and termination devices that provide protection for electronic systems from voltage spikes; power management products consisting of switching voltage regulators, combination switching and linear regulators, smart regulators, and charge pumps; and discrete semiconductor products, such as rectifiers, assemblies, and other products. It also offers wired communication, ultra-high speed Serializer/Deserializer, and modulator driver products that perform timing, synchronization, and amplification functions in high-speed networks; chips and transceivers for short reach, metro, and long haul applications; and high performance transceivers for datacenter applications. In addition, the company provides wireless and sensing products that perform radio frequency functions in indust rial, medical, and networking applications; and sensing functions in industrial and consumer applications. It serves original equipment manufacturers and their subcontractors in the computing, communications, consumer, and industrial end-markets directly, and through independent distributors and sales representative firms in North America, the Asia Pacific, and Europe. Semtech Corporation was founded in 1960 and is headquartered in Camarillo, California.

Advisors' Opinion:

• [By Jayson Derrick]

  After the market close yesterday, Semtech (NASDAQ: SMTC) lowered its fourth quarter guidance. The company sees revenue in a $120 million to $130 million range from a previous $132 million to $144 million range. EPS was lowered to a $0.18 to $0.24 range from a previous $0.29 to $0.37 range. Management blamed the lowered guidance on ��ngoing delays in carrier capex spending��Analysts at Oppenheimer downgraded shares to Perform from Outperform while Raymond James downgraded shares to Outperform from Strong Buy. Williams Financial also downgraded shares to Hold from Buy with a $27 price target, lowered from a previous $32. The analysts share similar beliefs that the company is showing no near-term growth drivers. Shares hit new 52 week lows of $22.57 before closing at $24.67, down 12.11 percent.

10 Best Clean Energy Stocks To Invest In 2014: Columbia Sportswear Company(COLM)

Columbia Sportswear Company, together with its subsidiaries, engages in the design, development, sourcing, marketing, and distribution of outdoor apparel, footwear, accessories, and equipment in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada. It provides apparel, accessories, and equipment for men, women, and youth under Columbia and Mountain Hardwear brands used during outdoor activities, such as skiing, snowboarding, hiking, climbing, mountaineering, camping, hunting, fishing, trail running, water sports, and adventure travel. The company also offers footwear products, including lightweight hiking boots, trail running shoes, rugged cold weather boots, sandals, and casual shoes for men and women under Columbia, Sorel, and Montrail brands, as well as for youth under the Columbia and Sorel brands. Columbia Sportswear Company sells its products through wholesale distribution channels, independent distributors, direct-to-consum er channels, and licensees, as well as online to independent distributors and consumers. As of December 31, 2011, it operated 43 outlet retail stores and 8 branded retail stores in the United States; 7 outlet retail stores and 3 branded retail stores in various locations in western Europe; and 2 outlet retail stores in Canada, as well as 111 and 236 dealer-operated, branded, outlet, and shop-in-shop locations in Japan and Korea. Columbia Sportswear Company was founded in 1938 and is headquartered in Portland, Oregon.

Advisors' Opinion:

• [By Ben Levisohn]

  Shares of Under Armour have dropped 5.2% to $79.59 at 1:21 p.m., while Dick’s has dropped 0.8% to $51.32. Nike (NKE) is little changed at $75.58, Skechers USA (SKX) has dropped 2.2% to $28.53 and Columbia Sportswear (COLM) has declined 0.1% to $62.75.

10 Best Clean Energy Stocks To Invest In 2014: Century Aluminum Company(CENX)

Century Aluminum Company, through its subsidiaries, produces primary aluminum in the United States, China, and Iceland. The company offers high purity primary aluminum, molten aluminum, standard-grade ingots, extrusion billets, and other value-added primary aluminum products. It also holds a 40% joint venture interest in a carbon anode and cathode facility located in the Guangxi Zhuang Autonomous Region of south China. The company was founded in 1981 and is headquartered in Monterey, California.

Advisors' Opinion:

• [By Rich Smith]

  This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines include upgrades for both Century Aluminum (NASDAQ: CENX  ) and Deutsche Bank (NYSE: DB  ) . But the news isn't all good, so let's start off with a few words on why...

• [By Pendulum]

  Amid the challenges in the aluminum industry, Century Aluminum (CENX) has taken positive actions over the last few months. In June, it acquired the Sebree smelter in Kentucky. More importantly, it received approval for a new power contract at its Hawesville facility, which will improve its cost structure, and the company has similar plans for the new Sebree facility. These actions are reducing the company's cost of production and putting it in a better position to manage through the tough part of the aluminum price cycle. As a result of these actions, Century Aluminum's stock price has outperformed its peers. In this article, I will analyze the challenges in the aluminum industry and the positive impact of Century Aluminum's recent actions.

• [By Rich Smith]

  Even as it contemplates shutting down its largest aluminum smelter in the United States, Century Aluminum (NASDAQ: CENX  ) says it's planning to buy another smelter entirely. On Monday, Century announced that it's signed a definitive agreement to buy Rio Tinto's (NYSE: RIO  ) Sebree aluminum smelter in Henderson County, Ky.

• [By Travis Hoium]

  What: Shares of Century Aluminum (NASDAQ: CENX  ) jumped 13% today after the company announced an acquisition.

  So what: The company is buying the Sebree aluminum smelter for about $61 million in cash from a subsidiary of Rio Tinto Alcan. Century will assume $71 million in working capital and won't be liable for historical environmental liabilities at the plant. �

10 Best Clean Energy Stocks To Invest In 2014: Safety Medical Products Ltd(SFP.AX)

Safety Medical Products Limited engages in the development, manufacture, and commercialization of medical products in Australia. The company offers Securetouch single use manual retractable safety syringes. It also provides a range of sterilized feminine hygiene products, including tampons, pads, and liners, under the Pureste brand name; and imports and distributes medical products. The company was founded in 2001 and is based in Perth, Australia.

10 Best Clean Energy Stocks To Invest In 2014: Boom Logistics Ltd(BOL.AX)

Boom Logistics Limited provides crane logistics and lifting solutions to resource, energy, utilities, and infrastructure sectors in Australia. The company provides managed lifting solutions, contractual maintenance programs, crane integration for high rise construction, engineering services and maintenance, and equipment hire services. It also involves in the sale of cranes and crane parts; and the provision of repairs and maintenance services. The company offers a range of cranes, lifting equipment, and heavy haulage vehicles, as well as access and ancillary equipment. Its solutions include mobile, project, crawler, and tower cranes; heavy haulage vehicles, such as prime movers and low loaders; low profile prime movers; overhead jacking systems; and travel towers, under-bridge units, trailer lifts, spider lifts, boom lifts, knuckle boom lifts, scissor lifts, one man lifts, material lifts, material handlers, generators, and compressors. Boom Logistics Limited operates in a range of industry sectors, primarily industrial maintenance, commercial construction, resources and petro chemical industry, civil works, and heavy lifting sectors. It offers approximately 530 cranes and 2,500 items of access equipment. The company, formerly known as Australian Crane Company, was incorporated in 2000 and is based in Southbank, Australia.

10 Best Clean Energy Stocks To Invest In 2014: Combined Group Contracting Co SAKC (CGCK.KW)

Combined Group Contracting Company KSCC is a Kuwait-based public shareholding company that operates in the construction industry. The Company�� activities include general contracting, mechanical and engineering works, construction of industrial and commercial buildings, bridges, and highways; manufacture and import of building materials; trade and packaging of cement, sand and related materials; ready-mix works; asphalt production; owning the transportation intermediaries for the Company�� activities, and the investment of excess funds in portfolios managed by specialized companies. The Company operates mainly in the State of Kuwait and other Gulf countries. As of December 31, 2011, the Company�� subsidiaries included Combined Group for Trading and Contracting Co WLL, Combined International Real Estate Company KSCC and Combined Group Contracting Company KSC, among others.

Credit Suisse’s Top Energy Stock Picks for 2014

While 2013 was a solid year for the energy sector, it could not keep pace with the overall blistering rise in the S&P. The energy team at Credit Suisse is positive on the year ahead, but they see some clear changes in the overall picture. The biggest one will be the overall volume of oil available. They are think that investing in energy may be volatile in 2014, but they see the top stocks in the sector going higher from current levels.

The Credit Suisse analysts have focused in on four important themes that may affect the energy sector in 2014. Their top stocks to buy reflect a close eye on these themes and the changing landscape in the world.

In 2014, oil markets may need to adjust to the wildcard of rising volumes out of Libya, Iran and Iraq. Any improvement in Middle East relations could up the ante in terms of supply. The U.S. service market is oversupplied at the low end, though high-tech providers can generate good terms. The top players should be able to remain on top. The majors are still one year away from a demonstrable payoff from their $250 billion investment programs. Big winners from 2013 are fully valued and investors may need to shift to other energy names. The analysts specifically mention the master limited partnerships and the refining stocks.

Here are the top energy stocks to buy from Credit Suisse for 2014.

Chevron Corp. (NYSE: CVX) is the only major domestic integrated on the Credit Suisse list. The company has benefited greatly in 2013 from record oil and natural gas production in the United States. The company may be looking to expand domestic production by acquiring one of the top exploration and production stocks. Investors are paid a solid 3.4% dividend. The Credit Suisse price target is $140. The Thomson/First Call estimate is $135. Chevron closed Thursday at $123.22.

Phillips 66 (NYSE: PSX) is a refiner that the Credit Suisse team is still very positive on. The Department of Defense declared this week that it granted a $292 million contract to Phillips 66 for aviation turbine fuel or jet fuel. Under this contract, Phillips 66 is to deliver jet fuel for 14 months, until April 30, 2015. According to the Pentagon, Phillips 66 knocked down 25 other firms for this job. Shareholders are paid a 2.2% dividend. The Credit Suisse price target for the stock is $80, and the consensus is at $79.50. Phillips 66 closed Thursday at $72.92.

Top Medical Companies To Watch In Right Now

Though many excited traders had hoped to see the bidding war continue between Valeant Pharmaceuticals (NYSE: VRX  ) and Merz over Obagi Medical Products (NASDAQ: OMPI  ) and a subsequent run-up in the stock price of the smaller dermatological products maker, Merz has now walked away from the table, leaving the highly acquisitive Valeant the victor. In this video, Motley Fool health care analyst David Williamson gives us some background on these companies and tells us how Valeant plans to profit from the deal, and describes for investors why this is a win both for Obagi and for Valeant.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of.�Click here now�to keep reading.

Top Medical Companies To Watch In Right Now: Organovo Holdings Inc (ONVO)

Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., incorporated in 2007, is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�� (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.

The Company has collaborative research agreements with Pfizer, Inc. (Pfizer) and United Therapeutic Corporation (Unither). As of March 31, 2012, it has five federal grants, including Small Business Innovation Research grants and developed the NovoGen MMX Bioprinter (its first-generation 3D bioprinter). The Company is engaged in the development of specific 3D human tissues to aid Pfizer in discovery of therapies in two areas of interest. In addition, in October 2011, it entered into a research agreement with Unither to establish and conduct a research program to discover treatments for pulmonary hypertension using its NovoGen MMX Bioprinter technology. Additionally, under the research agreement with Unither, the Company granted Unither an option to acquire from the Company a worldwide, royalty-bearing license in certain intellectual property created under the research agreement solely for use in the treatment or prevention of pulmonary hypertension and all other lung diseases.

The Company�� NovoGen MMX Bioprinter is an automate! d device that enables the fabrication of three-dimensional (3D) living tissues comprised of mammalian cells. A custom graphic user interface (GUI) facilitates the 3D design and execution of scripts that direct precision movement of the dispensing heads to deposit cellular building blocks (bio-ink) or supporting hydrogel. The Company is using a third party manufacturer, Invetech Pty., of Melbourne, Australia, to manufacture its NovoGen MMX Bioprinter. Its bioprinting technology and surrounding intellectual property and commercial rights serve as a platform for product generation across multiple markets that employ cell- and tissue-based products and services.

The Company competes with Organogenesis, Advanced BioHealing, Tengion, Genzyme, HumaCyte and Cytograft Tissue Engineering.

Advisors' Opinion:

• [By Keith Fitz-Gerald]

  In the 4D medical world, Organovo Holdings Inc. (NYSE MKT: ONVO) appears to be off to a good start. They've got a number of bioprinting projects centered around functional human tissue, including a liver product that's planned for 2014. I believe the company will quickly branch into tumor modeling, transplantation, and pharma research.

• [By Roberto Pedone]

  Organovo (ONVO) is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. This stock closed up 8.5% to $5.21 in Thursday's trading session.

  52-Week Range: $1.78-$8.50
  
  Thursday's Volume: 2.88 million
  
  Three-Month Average Volume: 1.78 million

  From a technical perspective, ONVO ripped higher here back above its 50-day moving average of $4.88 with heavy upside volume. This stock has been downtrending badly for the last month, with shares plunging lower from its high of $8.50 to its recent low of $4.43. During that downtrend, shares of ONVO have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of ONVO might be ready to see its downside volatility stop and reverse its downtrend and enter a new uptrend. The probability for that reverse in trend is supported by the high volume on Thursday.

  Traders should now look for long-biased trades in ONVO as long as it's trending above its recent low at $4.33 and then once it sustains a move or close above $5.21 to $5.64 with volume that hits near or above 1.78 shares. If we get that move soon, then ONVO will set up to re-test or possibly take out its next major overhead resistance levels at $6.65 to $7.50.

• [By Roberto Pedone]

  Another stock that's starting to move within range of triggering a near-term breakout trade is Organovo (ONVO), a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. This stock has been on fire so far in 2013, with shares up sharply by 133%.

  If you look at the chart for Organovo, you'll notice that this stock recently pulled back sharply from its high of $8.50 to its recent low of $4.43 a share. During that move, shares of ONVO were consistently making lower highs and lower lows, which is bearish technical price action. That said, the downside volatility stopped for ONVO once it hit $4.43 a share, and the stock has now reversed its downtrend and entered an uptrend. That move is quickly pushing ONVO within range of triggering a near-term breakout trade.

  Traders should now look for long-biased trades in ONVO if it manages to break out above some near-term overhead resistance levels at $6.20 to $6.65 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2 million shares. If that breakout triggers soon, then ONVO will set up to re-test or possibly take out its next major overhead resistance levels at $7.50 to its 52-week high at $8.50 a share. Any high-volume move above $8.50 will then put its all-time high at $10.90 within range for shares of ONVO.

  Traders can look to buy ONVO off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $5.07 a share, or just below $5 a share. One can also buy ONVO off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Medical Companies To Watch In Right Now: Prima BioMed Ltd (PBMD)

Prima BioMed Ltd is a biotechnology company is engaged in the development and commercialization of medical therapies with a focus on oncology. Its product candidates in development include Cvac, an autologous dendritic cell vaccine for ovarian cancer, monoclonal antibodies for multiple tumour types, and an oral formulation for the human papilloma virus (HPV), vaccine. Its product candidate Cvac is a dendritic cell therapy, for which it is conducting a Phase IIb trial for the treatment of ovarian cancer. Cvac is designed to target the tumour antigen mucin-1, which is expressed at high levels on different tumour types. It also has two preclinical product development programs. In May 2011, Prima BioMed GmbH, a 100 % owned subsidiary of Prima BioMed Ltd, was incorporated in Germany. In May 2011, Prima BioMed Middle East FZLLC, a 100 % owned subsidiary of Prima BioMed Ltd, was incorporated in the United Arab Emirates. Advisors' Opinion:

• [By Monica Gerson]

  Prima Biomed (NASDAQ: PBMD) shares dipped 38.59% to touch a new 52-week low of $1.44 after the company reported top-line analysis of CVac Phase 2 trial.

• [By Monica Gerson]

  Prima Biomed (NASDAQ: PBMD) dropped 38.17% to $1.45 after the company reported top-line analysis of CVac Phase 2 trial.

  Tower Group International (NASDAQ: TWGP) plummeted 24.31% to $10.49. Tower Group announced its plans to release its Q2 results during the week of October 7, 2013. FBR Capital downgraded the stock from Outperform to Market Perform.

Hot Canadian Stocks To Buy For 2014: Inergetics Inc (NRTI)

Inergetics, Inc., formerly Millennium Biotechnologies Group, Inc., incorporated on November 9, 2000, is a holding company for its sole operating subsidiary, Millennium Biotechnologies, Inc. (Millennium). The Company through its subsidiary Millennium, engages in the research, development, and marketing of specialized nutritional supplements as an adjunct to medical treatments for select medical conditions, as well as for athletes seeking improved recovery and advanced performance. The Company markets products, which are targeted toward immuno-compromised individuals undergoing medical treatment for diseases, such as cancer, as well as wound healing and post-surgical healing and geriatric patients in long-term care facilities among other conditions. In January 2013, the Company acquired Bikini Ready and SlimTrim brands from Whole Products Group.

The Company�� product portfolio include, Resurgex Select, Ready-To Drink Resurgex Essential and Ready-To-Drink Resurgex Essential Plus. Resurgex Select is a whole foods-based, calorically dense, high-protein powdered nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex Essential and Resurgex Essential Plus represent Millennium�� Ready-to-Drink product line and are being sold into the Long-Term Care geriatric markets.

Resurgex Select

Resurgex Select is a whole foods-based nutritional product that is designed to be used throughout the course of cancer treatment (chemotherapy, radiation, etc.), as many times patients lose weight and cannot consume adequate nutrition. This product combines dietary fiber (3 g), low sugar (5 g), and high protein (15 g) with no added antioxidants to be a high-calorie (350 calorie) supplement. It is available in three flavors (Vanilla Bean, Chocolate Fudge, and Fruit Smoothie) and each can be mixed with water, milk, juices, or in soft cold foods, such as yogurt, apple sauce or pudding.

Surgex

Surgex (www.surgexspor! ts.com), is a nutritional support formula that aims to address the concerns of many elite athletes who suffer from symptoms, such as fatigue, lean muscle loss, lactic acid buildup, oxidative stress, and stressed immune systems. This formula is designed to improve recovery parameters in efforts to enhance the performance of professional and collegiate athletes.

Resurgex Essential

The Essential line is a ready-to-drink alternative to Ensure and Boost designed to be marketed into the long-term care channel. Resurgex Essential has 250 whole food calories containing no corn syrup or corn oil. The product also contains fruit and vegetable extracts, and FOS Fiber to provide calories and taste.

The Company competes with Nestle and Abbott Laboratories Inc.

Top Medical Companies To Watch In Right Now: DENTSPLY International Inc.(XRAY)

DENTSPLY International Inc. designs, develops, manufactures, and markets dental consumable products, dental laboratory products, and dental specialty products worldwide. The company?s dental consumable products include dental sundries, such as dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment, including high and low speed handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers used in dental offices for the treatment of patients. Its dental laboratory products comprise dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as equipment, such as computer aided machining ceramic systems and porcelain furnaces used in the preparation of dental appliances by dental laboratories. The company?s dental specialty products consist of endodonti c instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, and orthodontic appliances and accessories. Its customers include dentists, dental hygienists, dental assistants, dental laboratories, and dental schools. The company distributes its dental products directly to dental laboratories and dental professionals, as well as through distributors, dealers, and importers. DENTSPLY International Inc. was founded in 1983 and is headquartered in York, Pennsylvania.

Advisors' Opinion:

• [By Monica Gerson]

  DENTSPLY International (NASDAQ: XRAY) shares touched a new 52-week high of $47.65. DENTSPLY's trailing-twelve-month ROE is 15.95%.

  Sun Life Financial (NYSE: SLF) shares gained 2.47% to create a new 52-week high of $34.80 on Q3 results. Sun Life reported its Q3 operating net income from continuing operations of $422 million.

Top Medical Companies To Watch In Right Now: Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc. (Oncolytics), incorporated on April 2, 1998, is a development-stage company. The Company is focused on its research and development of REOLYSIN, which is its cancer therapeutic. REOLYSIN is developed from the reovirus. This virus has been demonstrated in tumour cells bearing an activated Ras pathway. Oncolytics is directing a clinical trial program with the focus of developing REOLYSIN as a human cancer therapeutic. The clinical program includes clinical trials, which it sponsors directly along with Third Party Clinical Trials. Third Party Clinical Trials are clinical trials that are being sponsored by other institutions. As of December 31, 2011, the United States National Cancer Institute (NCI), the University of Leeds and the Cancer Therapy & Research Center at the University of Texas Health Center in San Antonio (CTRC) were sponsoring part of its clinical trial program.

The Company�� clinical trial program has included human trials using REOLYSIN alone, and in combination with radiation and chemotherapy, and delivered via local administration and/or intravenous administration. Oncolytics uses contract toll manufacturers to produce REOLYSIN. On December 31, 2011, the Company had two wholly owned subsidiaries, Oncolytics Biotech (Barbados) Inc. (OBB) and Valens Pharma Ltd. Oncolytics Biotech (US) Inc. and Oncolytics Biotech (U.K.) are wholly owned subsidiaries of OBB.

Advisors' Opinion:

• [By Maxx Chatsko]

  T-VEC is not your traditional biologic drug. It is actually a bioengineered form of the herpes virus that, once injected into cancerous tumors, replicates, and produces an immune-stimulating protein that puts a bulls eye on cancer cells throughout the body. Despite its promise and intriguing mechanism of action, T-VEC is not in further development at Amgen. However, Oncolytics (NASDAQ: ONCY  ) has shown promising results for its bioengineered form of reovirus called Reolysin. Initial phase 3 results showed that 86% of patients taking the drug had reduced tumor mass or growth after six weeks of treatment. �

• [By John Udovich]

  The biotech sector along with small cap biotech stocks Cardiome Pharma Corp (NASDAQ: CRME), Oncolytics Biotech, Inc (NASDAQ: ONCY), Vital Therapies Inc (NASDAQ: VTL) and TNI BioTech (OTCMKTS: TNIB) have all been producing their share of news this week for investors and traders alike to trade on. Moreover and while some 42 ��ife sciences��companies have gone public raising about $3 billion from investors so far this year, there are a growing number of biotechs pulling the plug on upcoming IPOs who are citing market conditions. With that in mind, here is a look at important news from the biotech sector and small cap biotech stocks this week:

• [By Sean Williams]

  With this in mind, I feel it'd be prudent of biotech-savvy investors to give Oncolytics Biotech (NASDAQ: ONCY  ) a closer look.

  The big risks
  I'm quite aware that there are a lot factors that'd raise a red flag with Oncolytics. Similar to Affymax, you could say that Oncolytics has put all of its eggs in one basket with its lead experimental drug, reolysin. According to Oncolytics' website, including its U.K., Canadian, and U.S. studies, reolysin as either a monotherapy or combination therapy is the basis for all 31 clinical trials! Obviously, if reolysin proves ineffective or unsafe, Oncolytics is going to be a world of hurt.

Top Medical Companies To Watch In Right Now: Paradigm Medical Industries Inc (PDMI)

Paradigm Medical Industries, Inc., incorporated in October 1989, develops, manufactures, markets and sells ophthalmic diagnostic instrumentation and related accessories, including disposable products. The diagnostic products that the Company manufacturers, markets and sells consist of the P60 UBM Ultrasound Biomicroscope, two perimeters - the LD 400 and the TKS 5000, and the Blood Flow Analyzer. The diagnostic products that the Company markets and sells, which are manufactured by its Italian partner, Costruzione Strumenti Oftalmici srl (CSO), are the Paramax, corneal topographers - the Paravue 300 and the Surveyor 500, and the Paracam 1000. The P60 UBM Ultrasound biomicroscope is the third-generation of UBM devices. The CSO product to be distributed and sold by the Company is the Paramax. Other CSO products to be sold by the Company are the Paravue 300, a corneal topographer with the ability to display live images on a computer monitor; the Surveyor 500, a corneal topographer with a rotating Scheimpflug camera with placido disk, and the Paracam 1000, a specular microscope for endothelial cell evaluations.

Diagnostic Eye Care Products

The Company�� diagnostic eye care products include blood flow analyzer, dicon perimeters, P60 UBM ultrasound biomicroscopes, and Paramax and other products manufactured by Costruzione Strumenti Oftalmici srl. The blood flow analyzer device measures not only intraocular pressure but also pulsatile ocular blood flow, the reduction of which may cause nerve fiber bundle death through oxygen deprivation thus resulting in visual field loss associated with glaucoma. The Company's blood flow analyzer is a portable automated in-office system that presents a method for ocular blood flow testing for the ophthalmic and optometric practitioner. The device is a portable desktop system that utilizes an Air Membrane Applanation Probe (AMAP), which can be attached to any model of standard examination slit lamp, which is then placed on the cornea of the patient! 's eye to measure the intraocular pressure within the eye.

Dicon perimeters consist of the LD 400 and the TKS 5000, and software consisting of Field Lin FieldView and Advanced Field View. Perimeters are used to determine retinal sensitivity testing the visual pathway. Perimetry is reimbursable worldwide. The Dicon perimeters feature kinetic fixation and voice synthesis in 27 different languages. The LD 400FT, or Fast Threshold Autoperimeter, is the successor to the LD 400. The device is an autoperimeter used to measure patient visual fields. The LD 400FT is identical in hardware to the LD 400 but it uses new software to enable a threshold test. The P60 biomicroscope represents the third-generation of UBM devices. The Paramax is to be sold in North America on an exclusive basis. The Paramax performs tests for the early screening and follow up of pathologies, such as glaucoma, age related macular degeneration, vascular retinal degeneration, and other optic nerve diseases.

Surgical Products

The Company�� surgical products include Precisionist Thirty Thousand, Ocular Surgery Workstation and Photon Laser System. The Precisionist Thirty Thousand is the Company's core phaco surgical technology. As of December 31, 2009, the Precisionist is not manufactured by the Company. The system features a graphic color display and on board computer and graphic user interface linked to a soft key membrane panel for flexible programmable operation. The system provides real-time on-the-fly adjustment capabilities for each surgical parameter during the surgical procedure for high-volume applications. In addition, the Precisionist provides one hundred pre-programmable surgery setups, with a second level of subprogrammed custom modes within each major surgical screen (ultrasound phaco and

irrigation/aspiration modes).

The Ocular Surgery Workstation comprises the base system of the Precisionist

Thirty Thousand and is the first system, to the Company's knowledge,! which us! es the expansive capabilities of today's advanced computer technology to offer seamless open architecture expandability of the system hardware and software modules. The Workstation utilizes an embedded open architecture computer developed for the Company and controlled by a software system developed by the Company that interfaces with all components of the system. Ultrasound, fluidics (irrigation), aspiration, venting, coagulation and anterior vitrectomy (pneumatic) are all included in the base model.

The Photon laser cataract system is designed to be installed as a seamless plug-in upgrade or add-on to the Company's Precisionist' Ocular Surgery Workstation. The Photon laser utilizes the on board microprocessor computer of the Workstation to generate short pulse laser energy developed through the patented LCP to targeted cataract tissue inside the eye, while simultaneously irrigating the eye and aspirating the diseased cataract tissue from the eye. In addition to the cataract surgery equipment, the Company's surgical systems are designed to utilize accessory instruments and disposables. These include replacement ultrasound tips, sleeves, tubing sets and fluidics packs, instrument drapes and laser cataract probes. The Company focuses on expanding its disposable accessories as it penetrates the cataract surgery market and expands the treatment applications for its Workstation.

The Company competes with Sonomed, Tomey, Nidek, OTI and Quantel.

Top Medical Companies To Watch In Right Now: Amarantus Bioscience Holdings Inc (AMBS)

Amarantus BioScience Holdings, Inc., formerly Amarantus BioSciences, Inc., incorporated on March 22, 2013, is focuses on developing intellectual property and proprietary technology in order to develop drug candidates and diagnostic blood tests to diagnose and treat human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), owns the intellectual property rights to biomarkers related to oncology and neurodegeneration named BC-SeraPro and NuroPro respectively, has a license to an Alzheimer�� disease blood test named LymPro, and owns a number of proprietary cell lines called PhenoGuard. MANF was the first therapeutic protein discovered from a PhenoGuard Cell Line. In December 2012, the Company acquired neurodegenerative diagnostic portfolio from Power3 Medical Products. On March 22, 2013, the Company was merged with into Amarantus Bioscience Inc.

The Company also owns an inventory of 88 cell lines that Amarantus refers to as PhenoGuard Cell Lines. MANF is a protein that corrects protein misfolding. The Company�� MANF product development effort is centered on a therapy for Parkinson�� disease.

Advisors' Opinion:

• [By Bryan Murphy]

  I've taken bullish swings on - and been wrong to do so - Amarantus BioScience, Inc. (OTC:AMBS) before. My most recent bullish call on the budding biotech name was in April... a rally that fizzled shortly after I said it was just getting started. Somehow though, I find myself coming back to AMBS as a breakout candidate. This time, however, it's for a slightly different reason.

• [By Bryan Murphy]

  Two weeks ago I penned some bullish thoughts on Amarantus BioScience, Inc. (OTC:AMBS). In simplest terms, I liked the way the stock had spent some time in consolidation mode, and looked like was testing the upper boundary of that zone - I figured a breakout from AMBS was imminent. So I waited... and waited.... and waited. Nothing. A week and a half later, I let the stock fall off my mental radar. As it turns out, I should have been a little more patient. Amarantus BioScience finally did the deed yesterday, and is following through today.

Top Medical Companies To Watch In Right Now: StemCells Inc (STEM.W)

StemCells, Inc. (StemCells), incorporated in August 1988, is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies, and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. The Company�� primary research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The Company has two therapeutic product development programs, including its CNS Program, which is developing applications for HuCNS-SC cells, its human neural stem cell product candidate, and its Liver Program, which is characterizing the Company�� human liver cells as a therapeutic product.

CNS Program

The Company in its CNS Program, is in clinical development with its HuCNS-SC cells for a range of disorders of the central nervous system. The CNS includes the brain, spinal cord and eye. In February 2012, the Company had completed a Phase I clinical trial in Pelizeaus-Merzbacher Disease (PMD), a fatal myelination disorder in the brain.

The Company�� CNS Program is focused on developing clinical applications, in which transplanting HuCNS-SC cells protect or restore organ function of the patient before such function is irreversibly damaged or lost due to disease progression. The Company�� initial target indications are PMD, and more generally, diseases in which deficient myelination plays a central role, such as cerebral palsy or multiple sclerosis; spinal cord injury, disorders in which retinal degeneration plays a central role, such as age-related macular degeneration or retinitis pigmentosa. The Company�� product candidate, HuCNS-SC cells, is a purified and expanded composition of normal hum an neural stem cells. Its HuCNS-SC cells can be directly tr! a! nsplanted.

Liver Program

Liver stem or progenitor cells offer an alternative treatment for liver diseases. A liver cellular therapy or cell-based therapeutic provide or support liver function in patients with liver disease. The Company held a portfolio of issued and allowed patents in the liver field, which cover the isolation and use of both hLEC cells and the isolated subset, as well as the composition of the cells themselves.

The Company�� range of cell culture products, which are sold under the SC Proven brand, includes iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff N2, and NDiff N2B27. Its iSTEM is a serum-free, feeder-free medium that maintains mouse embryonic stem cells in their pluripotent ground state by using selective small molecule inhibitors to block the pathways, which induce differentiation. RHB-A is a defined, serum-free culture medium for the selective culture of human and mouse neural stem cells and their maintenanc e and expansion as adherent cell populations. RHB-Basal is a defined, serum-free basal medium. When supplemented with specific growth factors, this media is formulated for the propagation and differentiation of adherent neural stem cells. RHB-Basal can also be tailored to specific-cell type requirements by the addition of customer preferred supplements.

The Company�� NDiff N2 is a defined serum-free scell culture supplement for the derivation, maintenance, expansion and/or differentiation of human and mouse embryonic stem (ES) cells and tissue-derived neural stem cells supplement. Its NDiff N2-AF is a serum-free and animal component-free version of NDiff N2. Its NDiff N2B27 is a defined, serum-free medium for the differentiation of mouse embryonic stem cells to neural cell types. NDiff N27-AF is a serum-free and animal component-free version of NDiff N27. Its GS1-R is a serum-free media formulation shown to enable the derivation and long-term maintenance of tr ue, germline competent rat embryonic stem cells without! the ! ad! dition ! of cytokines or growth factors. Its GS2-M is a defined, serum- and feeder-free medium for the derivation and long-term maintenance of true, germline competent mouse iPS cells.

The Company also markets a number of antibody reagents for use in cell detection, isolation and characterization. These reagents are also under the SC Proven brand and it includes STEM24, STEM101, STEM121 and STEM123. Its STEM24 is a human antibody that recognizes human CD24, also known as heat stable antigen (HSA), a glycoprotein expressed on the surface of many human cell types, including immature human hematopoietic cells, peripheral blood lymphocytes, erythrocytes and many human carcinomas. Its CD24 is also a marker of human neural differentiation. Its STEM101 is a human-specific mouse antibody that recognizes the Ku80 protein found in human nuclei. Its STEM121 is a human-specific mouse antibody that recognizes a cytoplasmic protein of human cells. Its STEM123 is a human-specific mouse antibody that recognizes human glial fibrillary acidic protein (GFAP).

The Company�� Other products marketed under SC Proven include total cell genomic DNA (gDNA), RNA and protein lysate reagents purified from homogenous stem cell populations for intra-comparative studies, such as Epigenetic fingerprinting, Southern, Western and Northern blots, PCR, RT-PCR and microarrays. This range of purified stem cell line lysates includes mouse embryonic stem (ES) cells propagated in SC Proven 2i inhibitor-based GS2-M media and mouse ES cell-derived and fetal tissue-derived neural stem (NS) cells propagated in SC Proven RHB-A media.

5 Things to Watch on Wall Street This Week

Top 5 Performing Companies For 2014

Bloomberg via Getty ImagesSteelcase, a leading maker of office furniture, reports this week; its earnings are a bellwether of how corporate America is faring. You can never know in advance all the news that will move the market in a given week, but some things you can see coming. From a pair of leading office furniture companies reporting on the same day to a popular used-car seller showing off its showroom, here are some of the things that will help shape the week that lies ahead on Wall Street. Monday -- New Energy for the New Week: The new trading week kicks off with FuelCell Energy (FCEL) reporting. The builder of fuel cell power plants reports its latest quarterly results after the market closes on Monday. It's been 10 years since FuelCell completed its first commercial fuel cell plant installation. Business is starting to pick up, as it has as many orders over the past two years combined as it did during the eight previous years combined. Revenue should continue to grow as FuelCell grows closer to profitability. Tuesday -- Lone Wolf: Disney's (DIS) "The Lone Ranger" was a flop earlier this year. It failed to break $90 million in domestic box office receipts, and the $260 million it amassed in gross ticket sales worldwide wasn't enough to offset its massive production budget and cinematic distribution. Disney had fared well with Johnny Depp and director Gore Verbinski before. The two teamed up for the blockbuster success of Disney's "The Pirates of the Caribbean" movie series. It convinced a jaded audience to return to the local multiplex for a movie about swashbucklers. But it couldn't revive the Western genre this time around. Despite being a box office bomb, "The Lone Ranger" will get a chance at new life in the home market. It comes out on Blu-ray and DVD on Tuesday. Wednesday -- Office Space: When it comes to stocks, it's safe to say that Steelcase (SCS) and Herman Miller (MLHR) aren't exactly the busy bees of the exchanges. On a typical day you will see roughly 250,000 to 400,000 shares traded. However, when both companies step up to report quarterly results on Tuesday, you can bet that a lot more than just their investors will be tuning in. As leading makers of office furniture -- Herman Miller is actually credited with inventing the cubicle, for better or worse -- checking out how the two companies are doing is a smart way for investors to take the pulse of corporate America. Spoiler alert: Wall Street sees both companies posting improving sales and earnings on Tuesday. Thursday -- Olive Garden and Red Lobster Have a Lot to Prove: Darden Restaurants (DRI) has been struggling as the hungry avoid its flagship casual-dining concepts. Olive Garden and Red Lobster experienced a dip in comparable-restaurant sales in Darden's most recent quarter, and now it's up again. Darden reports on Wednesday. Darden's tried to offset the sting with its meaty dividend and expanding its smaller concepts, but until it fixes the fading popularity of Olive Garden and Red Lobster, it's going to be hard for investors to get excited about the restaurateur. Friday -- I Want to Sell You a Used Car: Being called a used-car salesman used to be an insult along the lines of selling snake oil, but CarMax (KMX) has cleaned things up. CarMax has been growing its huge showrooms selling spruced-up secondhand cars in a clean and haggle-free environment. CarMax will also buy your car, even if you're not there to buy another one. CarMax reports on Friday, and investors aren't likely to suffer sticker shock. Analysts see healthy double-digit percentage growth on both ends of the income statement for the quarter. Both new and used car sales in this country have been strong lately, and that's good news for investors revving up in CarMax stock.